June 19, 2017Comments Off on New test may turn AZ’s Lynparza into precision drug for prostate cancer
LONDON (Reuters) – Scientists have developed a new three-in-one blood test that has the potential to turn AstraZeneca’s drug Lynparza into a precision medicine for prostate cancer. Reuters: Health News... Read More
June 15, 2017Comments Off on Pfizer, Roche and Aspen face South African probe into cancer drug prices
PRETORIA (Reuters) – South Africa’s competition watchdog has launched an investigation into three drug companies accused of over-charging for cancer medicines, the agency’s chief said on Tuesday. Reuters: Health News... Read More
June 12, 2017Comments Off on Roche CEO still optimistic on new breast cancer drug
VIENNA (Reuters) – Roche is convinced a new breast cancer drug will have a significant role in treating the disease despite recent trial results that disappointed analysts, the Swiss drugmaker’s... Read More
May 22, 2017Comments Off on Higher rate of heart problems seen with Amgen bone drug in trial
(Reuters) – Amgen Inc and UCB SA said on Sunday they did not expect their experimental osteoporosis drug to win U.S. approval this year after a higher rate of serious... Read More
May 17, 2017Comments Off on FDA warns of foot, leg amputations with J&J diabetes drug
(Reuters) – Johnson & Johnson is required to add new warnings to its diabetes drug, Invokana, about the risk of foot and leg amputations, the U.S. Food and Drug Administration... Read More
May 11, 2017Comments Off on AstraZeneca asthma drug fails, after similar setback at Roche
(Reuters) – An experimental biotech drug for severe asthma from AstraZeneca failed to meet its goal of significantly reducing attacks in a late-stage study, dealing a blow to an approach... Read More
May 1, 2017Comments Off on U.S. FDA approves Takeda’s lung cancer drug as second-line treatment
(Reuters) – Japan’s Takeda Pharmaceutical Co Ltd said on Friday that the U.S. Food and Drug Administration approved its lung cancer drug, almost three months after the company acquired the... Read More
April 16, 2017Comments Off on U.S. FDA declines to approve Eli Lilly and Incyte arthritis drug Olumiant
WASHINGTON (Reuters) – The U.S. Food and Drug Administration on Friday declined to approve a new drug for rheumatoid arthritis made by Eli Lilly and Co and partner Incyte Corp,... Read More
March 28, 2017Comments Off on New budget test puts UK on front line in global drug price fight
LONDON (Reuters) – Can society afford modern medicines? It’s a question facing governments worldwide and nowhere more so than in Britain, where a new budget test due to take effect... Read More
March 8, 2017Comments Off on Trump says he is working on plan to bring down drug prices
WASHINGTON (Reuters) – President Donald Trump said on Tuesday he is developing a plan that will encourage competition in the drug industry and bring down prices for medicines, as the... Read More
